VFY

VITRAFY FPO [VFY]
Vitrafy Life Sciences Limited engages in the research, development, and commercialization of cryopreservation solutions in Australia. The company offers smart devices, such as smart cryopreservation, smart thawing, and smart packaging devices. It also provides a software platform, which controls, trace, tracks, and monitors quality of cryopreserved biomaterials under the LifeChain brand. The company's cryopreservation technology is used various applications, such as blood platelets, cell and gene therapies, and aquaculture and bovine breeding programs. Vitrafy Life Sciences Limited was incorporated in 2017 and is based in Melbourne, Australia.
Technology · ASX Small Cap
$3.9300 -4.2%

Updated 3 Sep 2026 · Signals refresh every scan

Appeared in 2 consecutive scansFirst seen: 2026-03-24
Get alerts when VFY triggers a new signal
Free watchlist with daily scans for 2,200+ ASX stocks
Track VFY — Free

Active Signals

Bullish Signals

  • Trading above both moving averages — the trend is your friend here
  • Smart money may be accumulating — volume is flowing in even though price hasn't moved yet
  • Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
  • Trading above the 200-day average — the long-term trend is on your side
  • Strong cash runway (10 quarters)
  • Very high P/S ratio (1451.9x)
  • Sentiment is mixed — no strong consensus either way
  • Strong long-term momentum — up 166% over the past year (excluding last month)
  • Excellent risk-adjusted returns — Sharpe of 1.9 means strong gains without wild swings
  • The bigger volume days are the up days — volume-weighted momentum is positive (1.39%/day)
  • Beneish M-Score -1.09 > -1.78: likely earnings manipulation
  • RBA hiking (-3pts)

Risk Signals

  • Piotroski F-Score weak (3/9, low-confidence approx)
  • Not enough chatter to gauge sentiment — defaulting to neutral
Ask Scout AI about VFY
"What's driving VFY today?" "How does VFY compare to peers?" "Key risks for VFY?"
3 free messages/day · Unlimited with Pro

Recent Catalysts

NONE Vitrafy enters U.S. Cell & Gene Therapy Market
NONE FY26 Corporate Governance Statement
NONE FY26 Appendix 4G
LOW FY26 Appendix 4E and Annual Report

Recent ASX Announcements

2026-09-01 Vitrafy enters U.S. Cell & Gene Therapy Market PRICE SENSITIVE
2026-08-03 FY26 Corporate Governance Statement
2026-08-03 FY26 Appendix 4G
2026-08-03 FY26 Full Year Results Presentation PRICE SENSITIVE
2026-08-03 FY26 Appendix 4E and Annual Report PRICE SENSITIVE

Key Metrics

$303.4M
Market Cap
82K
Avg Volume
0.7x
Vol Ratio
$1.16 — $4.66
52-Week Range
N/A
Short Interest
N/A
Cash Runway
-46.3%
ROE
N/A
Profit Margin

CANSLIM Analysis

FactorRatingDetail
CCurrent EPSfailEPS Growth: 0%
AAnnual EarningsfailCAGR: 0%
NNew Highs / Catalystsneutral
SSupply & DemandneutralFloat: 66%
LLeader vs LaggardpassRS: 6
IInstitutional SponsorshipweakInst: 2%
MMarket DirectionneutralNeutral

Sector: Technology

96 tickers in this sector

View all Technology signals →Browse all ASX tickers A–Z →
Related Tickers
SIS -20.0%AMS -16.7%ITS +16.7%EXT -16.7%FCT -14.3%
Compare:VFY vs SISVFY vs AMSVFY vs ITS
Scout Pro — Deeper Analysis for VFY
Try Pro free for 30 days
Share this analysis

Track VFY and 2,200+ ASX stocks

Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and exit management for every ASX small cap.

Open Dashboard — Free Free Screener
No credit card required